Doxycycline (DOX) is lipophilic and synthetic derivative of tetracycline. DOX is a bacteriostatic agent that is active against gram-positive and gram-negative aerobic and anaerobic bacteria, Mycoplasmas, Chlamydiae, Rickettsiae, and some Protozoa. It inhibits the protein synthesis by restricting the binding of RNA to 30S ribosomal subunit. It is used for inflammatory conditions; periodontitis and acute coronary syndromes, variety of cancers, pulmonary fibrosis, emphysema, asthma, acute lung injury and for prophylaxis of malaria. The aim of this study is to evaluate the pharmaceutical equivalence of the three different brands of doxycycline capsules available in Karachi, Pakistan. For this purpose three different brands of doxycycline capsules (100 mg) were randomly selected from the local market using probability tools and evaluated for quality control parameters which are weight variation, disintegration and dissolution tests specified by BP/USP (British and United state Pharmacopoeia). Weight variation values of all brands comply with USP limits. Disintegration time for all brands was within 15 minutes also complying with the USP specification. All brands exhibited more than 80% drug release within 20 minutes. The present outcomes suggest that all the three brands of doxycycline capsule available in Karachi meet the USP specification for quality control analysis.
Introduction
Doxycycline is a liphophilic and semi synthetic derivative of natural tetracyclines which is produced by Strep-* Corresponding author. tomyces sp. Bacteria [1] . It is a bacterioststic agent having a broad spectrum activity against Gram-positive and Gram-negative anaerobic and aerobic bacteria, Mycoplasmas, Chlamydiae, Rickettsiae, and some Protozoa [2] . Doxycycline was firstly invented and clinically developed by Pfizer Inc., New York in the early 1960s and marketed under the trade name Vibramycin [3] [4] . Mechanism of action of DOX is that it acts by restricting the binding of aminoacyl t-RNA to 30S ribosomes which helps in the inhibition of protein synthesis. Tetracyclines (e.g. DOX) are believed to hinder the mitochondrial protein synthesis that leads to the innovation of other effects, independent of their antimicrobial actions [5] [6] . Tetracycline has improved lipophilicity as compared to older tetracyclines, for example oxytetracycline and tetracycline [7] . Doxycycline demonstrates immune-modulating activities that have been used in the treatment of numerous inflammatory conditions mediated by matrix metalloproteinase (MMP-9) and recover inflammatory biomarkers in patients with abdominal aortic aneurysms. It helps to prevent periodontitis and acute coronary syndromes. In recent times, the advancement in the study of tetracycline has developed due to their ability to inhibit matrix metalloproteinase (MMPs) in a variety of cancers such as breast, colorectal, osteosarcoma, melanoma, leukemia and prostate cancers [8] . Additionally, doxycycline has shown favorable effects in trial models of pulmonary fibrosis, emphysema, asthma and acute lung injury [9] . It also has many additional properties such as they provide anti-resorption result and prevent tissue breakdown by the inhibition of clastic cells and the inhibition of mammalian collagenases respectively. DOX also blocks excess of tissue collagenases which is present in periodontitis (an inflammatory disease), consequently leading to enhanced formation of bone and collagen [10] . DOX is approved by only United State Food and Drug Administration (FDA) to be indication in short-term travelers for malaria as prophylaxis of Plasmodium falciparum where the strains are resistant to pyrimethamine-sulfadoxine and/or chloroquine [11] . Second-generation, doxycycline is rapidly and well absorbed (95%) after oral administration than first-generation due to their increase lipid solubility, being measurable in blood in less than 15 minutes [12] . It is available in the various pharmaceutical dosage forms and strengths such as suspension (25 mg/5ml and 50 mg/5ml), immediate (20 and 100 mg) and delayed release tablets (75, 100 and 150 mg), immediate (50, 75 and 100 mg) and delayed release capsules (40, 75 and 100 mg) [13] . Doxycycline is (4S,4aR,5S,5aR,6R,12aS)-4-(Dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-2-tetracenecarboxamide having molecular formula: C 22 H 26 N 2 O 9 with molecular mass: 444.434601 and the molecular structure in Figure 1 [14].
Methodology
We have purchased different brands of doxycycline hyclate capsules (USP) of 100 mg from the local market i.e. VIBRAMYCIN(VIB), DOXYN(DOXN) and DOXYCYCLINE(DOXC). Different physicochemical testing were performed to compare multinational brand with the local brands.
Weight Variation Test
Weight Variation (in process test) ensures that content of each dosage units is uniform during compression. For this 10 capsules of each brand was weighed on Electronic Balance FX-400 and calculated that weight of each capsule must be within BP/USP limits i.e. for capsules containing less than 300 mg NMT two capsules out of the sample may be outside ±10% of the average and all must be within 20%.
Disintegration Test
for this test we use a disintegration apparatus (Curro model no DS-0702) and Place one capsule in each of the six tubes of the basket and add a disc (if specified) Operate the apparatus by maintaining its temperature at 35˚C -39˚C using water or another liquid (unless specified )as the immersion fluid. Finally at the specified time, pick 
Dissolution Test
We perform this test on GDT-7L of Galvano Scientific dissolution apparatus. For this we Place the 900ml of water in the vessel, assemble the equipment and place it in the water-bath maintained at temperature 37˚C ± 0.5˚C. At the beginning of each test, put one capsule of each brand in a dry basket. Lower the basket into position before rotation. Instantaneously start rotation of the basket at 50 RPM. Withdraw a sample of 10 ml at 15, 30, 45 and 60 min respectively from each vessel. The sample must be taken from a zone midway between the surface of the dissolution medium and the top of the rotating basket, not less than 10 mm below the surface and at least 10 mm from the vessel wall. Determine the quantity of doxycycline dissolved as specified in USP. It is a best tool to evaluate the bioavailability of drug in vivo.
Results
The physicochemical parameters of different brands of doxycycline capsules (VIB 01, DOXN 02 and DOXC 03) were analyzed. Table 5 . Dissolution test demonstrate the result as VIB01 is 100.00%, DOXN 02 is 151.06% and DOXC 03 is 109.05% shown in Table 6 and Table 7 .
Discussion
The purpose of this research work is to evaluate and compare the quality standards of three brands of doxycycline capsules (VIB, DOXN and DOXC) commercially available in Karachi, Pakistan specification are given in Table 1 . For comparatively study, physicochemical testing such as weight variation, in-vitro dissolution and disintegration of doxycycline capsules (100 mg) were performed and evaluated. Dissolution, disintegration and Uniformity of weight (weight variation) are compendia standards to assess the quality of capsules.
Weight Variation
The weight variation values of VIB, DOXN and DOXC are given in Table 2 , Figure 2 , which shows that VIB 01 has the highest value of mean weight among all the three brands. According to USP the requirements of weight variation are met when out of 20 capsules of each brand the weight of not more than 2 capsules differs from the average weight by more than 10% ( Table 4) . Difference in weight between these 3 brands (VIB, DOXN and DOXC) of doxycycline capsules is due to the non-uniform amount of an API. Uniformity of weight serves as an indicator to amount of the active pharmaceutical ingredient i.e. doxycycline enclosed in the formulation as well as good manufacturing practices i.e. GMP. 
Disintegration

VIB and DOXN have less disintegration time as compared to DOXC which is show in
Dissolution
The absorbance and percentage of all brands of doxycycline (VIB, DOXN and DOXC) dissolved in 30 min are shown in Table 6 and Table 7, Figure 4 . As per USP official limits for doxycycline capsules, dissolved amount of doxycycline should NLT 80% (Q) of the labeled amount in 60 min and all the brands are under the specified limit. 
Conclusion
It is concluded that the results of all the tests (weight variation, disintegration and dissolution) of selected brands of doxycycline capsules (100 mg) exhibit some differences, but these variations are in specified limits.
